MindMaze Therapeutics Holding S.A. (RLFTY)
MindMaze Therapeutics Holding S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Geneva, GE, CH. The stock last traded at $0.42, up 0.00% on the session, giving a market capitalisation of $5.3M. Its beta of 2.84 implies it has historically moved more than the broad market.
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
MindMaze Therapeutics Holding S.A. is most often compared with the following Healthcare names: